NYSE American - Delayed Quote USD

cbdMD, Inc. (YCBD)

0.6850 +0.0091 (+1.35%)
At close: May 13 at 3:59 PM EDT
Loading Chart for YCBD
DELL
  • Previous Close 0.6759
  • Open 0.6816
  • Bid --
  • Ask --
  • Day's Range 0.6701 - 0.7075
  • 52 Week Range 0.5600 - 2.2300
  • Volume 144,008
  • Avg. Volume 339,585
  • Market Cap (intraday) 2.086M
  • Beta (5Y Monthly) 1.98
  • PE Ratio (TTM) --
  • EPS (TTM) -10.2900
  • Earnings Date May 15, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.00

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

www.cbdmd.com

52

Full Time Employees

September 30

Fiscal Year Ends

Recent News: YCBD

Performance Overview: YCBD

Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

YCBD
34.13%
S&P 500
9.47%

1-Year Return

YCBD
68.58%
S&P 500
26.61%

3-Year Return

YCBD
99.56%
S&P 500
28.51%

5-Year Return

YCBD
99.78%
S&P 500
81.21%

Compare To: YCBD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: YCBD

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    2.09M

  • Enterprise Value

    3.95M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.07

  • Price/Book (mrq)

    0.30

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -85.21%

  • Return on Assets (ttm)

    -17.64%

  • Return on Equity (ttm)

    -118.82%

  • Revenue (ttm)

    23.45M

  • Net Income Avi to Common (ttm)

    -23.98M

  • Diluted EPS (ttm)

    -10.2900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.5M

  • Total Debt/Equity (mrq)

    47.87%

  • Levered Free Cash Flow (ttm)

    -67.12k

Research Analysis: YCBD

Company Insights: YCBD

Research Reports: YCBD

People Also Watch